Company AI Risk Explorer
Loading the data…
Welcome to the Company AI Risk Explorer

This tool maps what large global companies say in public about AI risk. We reviewed public documents from roughly 200 of the world's largest companies. We coded every risk they acknowledge against the AI Risk Repository taxonomy.

Filter by company, sector, AI role, or risk. Compare what companies acknowledge against expert ratings of severity, sector vulnerability, and role responsibility.

← Back to the overview Company AI Risk Explorer

Companies × risks

Argenx

argenx is an immunology-focused biopharma company with emerging AI activity. It has established an AI Centre of Excellence and partners with IQVIA for AI-powered pharmacovigilance, but its AI integration is still in early/scaling phases.

We reviewed 1 public document from Argenx and found it acknowledges none of the 24 AI risks we looked for.

Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing

Documents we reviewed